, Guidelines for the clinical management and treatment of HIV infected adults in Europe, European AIDS clinical society, p.31, 2015.
A systematic review of the associations between dose regimens and medication compliance, Clin Ther, vol.23, p.11558866, 2001. ,
Better adherence with once-daily antiretroviral regimens: a meta-analysis, Clin Infect Dis Off Publ Infect Dis Soc Am, vol.48, pp.484-488, 2009. ,
Efavirenz/emtricitabine/tenofovir disoproxil fumarate fixed-dose combination: first-line therapy for all?, Expert Opin Pharmacother, vol.8, p.17266471, 2007. ,
The first once-daily single-tablet regimen for the treatment of HIV-infected patients. Drugs Today Barc Spain, vol.43, pp.427-442, 1998. ,
Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV, N Engl J Med, vol.354, pp.251-260, 2006. ,
Single-tablet regimens in HIV: does it really make a difference, Curr Med Res Opin, vol.30, pp.89-97, 2014. ,
Single-Tablet Regimens in HIV Therapy, Infect Dis Ther, vol.3, pp.1-17, 2014. ,
Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panel, Ann Intern Med, vol.156, p.22393036, 2012. ,
A single tablet regimen is associated with higher adherence and viral suppression than multiple tablet regimens in HIV+ homeless and marginally housed people, AIDS Lond Engl, vol.24, pp.2835-2840, 2010. ,
Impact of antiretroviral dosing frequency and pill burden on adherence among newly diagnosed, antiretroviral-naive HIV patients, Int J STD AIDS, vol.23, pp.351-355, 2012. ,
Factors associated with complete adherence to HIV combination antiretroviral therapy, HIV Clin Trials, vol.12, pp.71-78, 2011. ,
Self-reported adherence supports patient preference for the single tablet regimen (STR) in the current cART era, Patient Prefer Adherence, vol.6, p.22723727, 2012. ,
One-pill once-a-day HAART: a simplification strategy that improves adherence and quality of life of HIV-infected subjects, Patient Prefer Adherence, vol.4, p.20517472, 2010. ,
Does combining antiretroviral agents in a single dosage form enhance quality of life of HIV/AIDS patients? A cost-utility study, Res Soc Adm Pharm RSAP, vol.8, pp.157-165, 2012. ,
Adherence to antiretroviral treatment and correlation with risk of hospitalization among commercially insured HIV patients in the United States, PloS One, vol.7, p.31591, 2012. ,
Single-pill combination regimens for treatment of HIV-1 infection, N Engl J Med, vol.371, pp.248-259, 2014. ,
A large French prospective cohort of HIV-infected patients: the Nadis Cohort, HIV Med, vol.10, p.19486189, 2009. ,
Abacavir/lamivudine versus tenofovir DF/emtricitabine as part of combination regimens for initial treatment of HIV: final results, J Infect Dis, vol.204, pp.1191-1201, 2011. ,
, Bull Cancer (Paris), vol.94, pp.680-686, 2007.
Persistence and adherence to single-tablet regimens in HIV treatment: a cohort study from the French National Healthcare Insurance Database, J Antimicrob Chemother, vol.70, pp.2121-2128, 2015. ,
Adherence in HIV-positive patients treated with single-tablet regimens and multi-pill regimens: findings from the COMPACT study, J Int AIDS Soc, vol.15, p.18098, 2012. ,
Lower pill burden and oncedaily antiretroviral treatment regimens for HIV infection: A meta-analysis of randomized controlled trials, Clin Infect Dis Off Publ Infect Dis Soc Am, vol.58, pp.1297-1307, 2014. ,
Meta-Analysis of Studies Comparing Single and MultiTablet Fixed Dose Combination HIV Treatment Regimens, Medicine (Baltimore), vol.94, p.1677, 2015. ,
Patient-reported outcomes in the single-tablet regimen (STaR) trial of rilpivirine/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate in antiretroviral treatment-naive adults infected with HIV1 through 48 weeks of treatment, AIDS Care, vol.28, pp.401-408, 2016. ,
Efficacy, safety, and patient acceptability of elvitegravir/cobicistat/emtricitabine/tenofovir in the treatment of HIV/AIDS, Patient Prefer Adherence, vol.9, pp.1213-1218, 2015. ,
Prevalence of preexisting resistance-associated mutations to rilpivirine, emtricitabine and tenofovir in antiretroviral-naive patients infected with B and non-B subtype HIV-1 viruses, J Antimicrob Chemother, vol.68, pp.1237-1242, 2013. ,
Not all missed doses are the same: sustained NNRTI treatment interruptions predict HIV rebound at low-to-moderate adherence levels, PloS One, vol.3, p.18665246, 2008. ,
Predictors of virologic failure and resistance in HIV-infected patients treated with nevirapine-or efavirenz-based antiretroviral therapy, Clin Infect Dis Off Publ Infect Dis Soc Am, vol.38, pp.1311-1316, 2004. ,
Unanticipated Effects of New Drug Availability on Antiretroviral Durability: Implications for Comparative Effectiveness Research, Open Forum Infect Dis, vol.3, p.109, 2016. ,